The global artificial intelligence (AI) in genomics market is projected to grow from USD 0.5 billion in 2023 to USD 2.0 billion by 2028, at a CAGR of 32.3% during the forecast period. The rapid growth of this market is driven by the increasing need to accelerate drug discovery timelines, reduce development costs, and extract meaningful insights from vast genomic datasets.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36649899
The integration of AI technologies with genomics is transforming healthcare by enabling faster and more accurate analysis of genetic data. Growing investments, strategic partnerships, and collaborations among technology providers and life sciences companies are further fueling market expansion. Additionally, the rising adoption of precision medicine and the exponential growth of bioinformatics and genomic data are key factors driving demand.
Software Segment Leads Market by Offering
By offering, the software segment is expected to account for the largest share of the AI in genomics market during the forecast period. AI-powered software platforms play a critical role in analyzing large-scale genomic datasets, identifying disease-causing variants, and supporting clinical decision-making.
These solutions significantly reduce analysis time and improve the accuracy of genomic interpretation, making them indispensable for research institutions, pharmaceutical companies, and healthcare providers.
Pharmaceutical & Biotechnology Companies Dominate End-User Segment
By end user, pharmaceutical and biotechnology companies are expected to hold the largest and fastest-growing share of the market. The increasing need to streamline drug discovery and development processes is driving the adoption of AI-driven genomics solutions within this segment.
AI enables these organizations to identify novel drug targets, optimize clinical trials, and accelerate time-to-market, thereby improving overall R&D efficiency and reducing costs.
Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=36649899
Asia Pacific Emerges as Fastest-Growing Region
The Asia Pacific region is expected to register the highest growth rate in the AI in genomics market during the forecast period. Growth in this region is driven by increasing public and private investments, improving IT infrastructure, and growing demand for affordable healthcare solutions.
Countries such as China and India are witnessing a surge in genomics research projects, rising awareness of precision medicine, and increasing prevalence of chronic diseases and cancer. Favorable government initiatives and expanding adoption of next-generation sequencing (NGS) technologies are further supporting market growth.
Competitive Landscape
Key players operating in the AI in genomics market include NVIDIA Corporation (US), Microsoft Corporation (US), Google, Inc. (US), Intel Corporation (US), BenevolentAI (UK), FDNA, Inc. (US), DNAnexus (US), Engine Biosciences (US), Tempus Labs, Inc. (US), and Congenica Ltd (England), among others.
These companies are focusing on technological innovation, strategic collaborations, and expanding their AI capabilities to strengthen their position in the rapidly evolving genomics landscape.
